Covid Benefits: The Italian Billionaire Family Making Glass Vials For Vaccines Scores With U.S. IPO

The 72-year-old firm based in northern Italy debuted on the New York Stock Exchange in a rare public listing for an Italian company, adding $550 million to the Stevanato family’s coffers.


Join the Discussion

  • BrokerEUR/USD
    ETX Capital 0.6pips (variable) margin: 3.33%
    InterTrader 0.6pips (fixed) margin: 3.33%
  • Back to top